PALO ALTO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. today announced that it will report its third quarter 2009 financial results on Thursday, November 5, 2009. Jazz Pharmaceuticals will host an investor conference call and live webcast to give a company update, as well as to discuss financial results and guidance, on November 5, 2009, at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.
Investors may participate in the conference call by dialing 1-866-825-1692 in the U.S., or 1-617-213-8059 outside the U.S., and entering passcode 25459996.
CONTACT: Willie Quinn, Executive Director, Corporate Development of Jazz
Pharmaceuticals, Inc., investorinfo@jazzpharmaceuticals.com; or Karen L.
Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662, both of BCC
Partners for Jazz Pharmaceuticals, Inc.
Web site: http://www.jazzpharmaceuticals.com/
